Search
for
Sort by
Research 30 of 1000+
- Effect of finasteride on the ovulatory function of normal women
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- Progesterone-induced stimulation of mammary tumorigenesis is due to the progesterone metabolite, 5α-dihydroprogesterone (5αP) and can be suppressed by the 5α-reductase inhibitor, finasteride
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride
- The 5α-reductase inhibitor finasteride increases suicide-related aggressive behaviors and blocks clozapine-induced beneficial effects in an animal model of schizophrenia
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Finasteride inhibits the progesterone-induced spike-wave discharges in a genetic model of absence epilepsy
- Treatment of male rats with finasteride, an inhibitor of 5alpha-reductase enzyme, induces long-lasting effects on depressive-like behavior, hippocampal neurogenesis, neuroinflammation and gut microbiota composition
- Androgenetic alopecia; drug safety and therapeutic strategies
- Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind/Brain
- Safety concerns when using novel medications to treat alopecia
- Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice
- Discriminating in favour of or against men with increased risk of finasteride-related side effects?
- The effect of finasteride and dutasteride on the synthesis of neurosteroids by glioblastoma cells
- Post-finasteride syndrome – does it really exist?
- Finasteride inhibits melanogenesis through regulation of the adenylate cyclase in melanocytes and melanoma cells
- 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes
- Sexual dimorphism following in vitro ischemia in the response to neurosteroids and mechanisms of injury
- Altered Hormone and Bioactive Lipid Plasma Profile in Rodent Models of Polycystic Ovarian Syndrome Revealed by Targeted Mass Spectrometry
- Central Opioid Inhibition of Neuroendocrine Stress Responses in Pregnancy in the Rat Is Induced by the Neurosteroid Allopregnanolone
- Effects of Flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat
- Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?
- Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia